| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.098 | 0.02 |